|
pubmed:abstractText |
N-of-1 trials may enhance therapeutic precision by predicting the long-term effectiveness of medical treatment on an individual basis. However, the n-of-1 approach has gained little traction with the clinical community. To learn why, we interviewed physicians and patients, focusing on the perceived benefits and drawbacks of n-of-1 trials and factors influencing these perceptions.
|
|
pubmed:affiliation |
Division of General Medicine and Center for Healthcare Policy and Research, University of California, Davis, Sacramento, California, 95817, USA. rlkravitz@ucdavis.edu
|
